• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy.较小左心室捕捉阈值安全边际对改善心脏再同步化除颤治疗受者器械寿命的影响。
Am J Cardiol. 2015 Jul 1;116(1):85-7. doi: 10.1016/j.amjcard.2015.03.047. Epub 2015 Apr 8.
2
Estimation of the effects of multipoint pacing on battery longevity in routine clinical practice.评估多点起搏对常规临床实践中电池寿命的影响。
Europace. 2018 Jul 1;20(7):1161-1167. doi: 10.1093/europace/eux209.
3
Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.心脏再同步治疗除颤器的电池寿命。
Europace. 2014 Feb;16(2):246-51. doi: 10.1093/europace/eut301. Epub 2013 Oct 6.
4
Impact of multipoint pacing on projected battery longevity in cardiac resynchronization therapy. An IRON-MPP study sub-analysis.多点起搏对心脏再同步治疗中预计电池寿命的影响。IRON-MPP 研究的子分析。
J Cardiovasc Electrophysiol. 2019 Dec;30(12):2885-2891. doi: 10.1111/jce.14254. Epub 2019 Nov 5.
5
Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.无导线超声心内膜左心室再同步起搏治疗心力衰竭患者的可行性、安全性和短期疗效:无线刺激心内膜 CRT(WiSE-CRT)研究结果。
Europace. 2014 May;16(5):681-8. doi: 10.1093/europace/eut435. Epub 2014 Feb 4.
6
Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.当前临床实践中用于心脏再同步治疗的植入式心脏复律除颤器的使用寿命:根据影响因素、设备代次和制造商进行的分析
Europace. 2015 Aug;17(8):1251-8. doi: 10.1093/europace/euv109. Epub 2015 May 14.
7
Usefulness of Multisite Ventricular Pacing in Nonresponders to Cardiac Resynchronization Therapy.多部位心室起搏在心脏再同步治疗无反应者中的应用。
Am J Cardiol. 2022 Feb 1;164:86-92. doi: 10.1016/j.amjcard.2021.10.027. Epub 2021 Nov 20.
8
Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study.用于心脏再同步治疗的新型短双极间距左心室导线的性能:Attain Performa四极左心室导线研究的主要结果
Heart Rhythm. 2015 Apr;12(4):751-8. doi: 10.1016/j.hrthm.2014.12.019. Epub 2014 Dec 19.
9
Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads.带有四极左心室导联的心脏再同步治疗除颤器患者磁共振成像扫描的安全性。
Heart Rhythm. 2020 Dec;17(12):2064-2071. doi: 10.1016/j.hrthm.2020.08.020. Epub 2020 Sep 7.
10
Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports.心脏再同步治疗除颤器的电池寿命:制造商之间的差异以及与已发表的产品性能报告的不符之处。
Europace. 2017 Mar 1;19(3):421-424. doi: 10.1093/europace/euw044.

引用本文的文献

1
Novel active fixation lead guided by electrical delay can improve response to cardiac resynchronization therapy in heart failure.新型主动固定导联通过电延迟引导可改善心力衰竭患者心脏再同步治疗的反应。
ESC Heart Fail. 2022 Feb;9(1):146-154. doi: 10.1002/ehf2.13727. Epub 2021 Dec 24.
2
Ethical and Legal Implications of Remote Monitoring of Medical Devices.医疗器械远程监测的伦理和法律问题
Milbank Q. 2020 Dec;98(4):1257-1289. doi: 10.1111/1468-0009.12481. Epub 2020 Oct 20.
3
Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry.四极左心室导线对植入心脏再同步化治疗除颤器(CRT-D)患者心力衰竭住院率的影响:来自以色列植入式心律转复除颤器登记处的数据
J Interv Card Electrophysiol. 2018 Jan;51(1):5-12. doi: 10.1007/s10840-017-0305-z. Epub 2017 Dec 23.
4
Increased hs-CRP and decreased 1,25-dihydroxyvitamin D are associated with increased left ventricle lead threshold.
J Interv Card Electrophysiol. 2016 Nov;47(2):177-183. doi: 10.1007/s10840-016-0152-3. Epub 2016 May 28.

本文引用的文献

1
Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR.在电池寿命末期更换植入式心律转复除颤器后的死亡率风险:来自 NCDR 的结果。
Heart Rhythm. 2014 Feb;11(2):216-21. doi: 10.1016/j.hrthm.2013.10.046.
2
Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.延长器械寿命对植入式心脏转复除颤器治疗长期成本的影响:具有 15 年时间范围的建模研究。
Europace. 2013 Oct;15(10):1453-62. doi: 10.1093/europace/eut133. Epub 2013 May 21.
3
Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.心血管植入式电子设备置换感染与预防:REPLACE注册研究结果
Pacing Clin Electrophysiol. 2012 Jan;35(1):81-7. doi: 10.1111/j.1540-8159.2011.03257.x. Epub 2011 Nov 11.
4
Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.起搏器植入后的感染:在一项基于人群的队列研究中,对 46299 例连续患者的感染率和与感染相关的危险因素分析。
Eur Heart J. 2011 Apr;32(8):991-8. doi: 10.1093/eurheartj/ehq497. Epub 2011 Jan 20.
5
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.与起搏器或植入式心律转复除颤器(ICD)发生器更换和升级手术相关的并发症发生率:REPLACE 注册研究结果。
Circulation. 2010 Oct 19;122(16):1553-61. doi: 10.1161/CIRCULATIONAHA.110.976076. Epub 2010 Oct 4.
6
Fluctuation of left ventricular thresholds and required safety margin for left ventricular pacing with cardiac resynchronization therapy.心脏再同步治疗中左心室起搏的左心室阈值波动及所需安全 margins。 注:这里的“margins”直译为“边缘”,结合医学语境可能有更专业的表述,比如“余量”等,可根据具体专业知识进一步准确理解。
Europace. 2009 Jul;11(7):931-6. doi: 10.1093/europace/eup105. Epub 2009 May 12.
7
Automatic management of left ventricular stimulation: hints for technologic improvement.左心室刺激的自动管理:技术改进的提示
Pacing Clin Electrophysiol. 2009 Mar;32(3):346-53. doi: 10.1111/j.1540-8159.2008.02243.x.
8
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
9
Automated left ventricular capture management.
Pacing Clin Electrophysiol. 2007 Oct;30(10):1190-200. doi: 10.1111/j.1540-8159.2007.00840.x.
10
Cost-effectiveness of implantable cardioverter-defibrillators.植入式心脏复律除颤器的成本效益
N Engl J Med. 2005 Oct 6;353(14):1471-80. doi: 10.1056/NEJMsa051989.

较小左心室捕捉阈值安全边际对改善心脏再同步化除颤治疗受者器械寿命的影响。

Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy.

作者信息

Steinhaus Daniel A, Waks Jonathan W, Collins Robert, Kleckner Karen, Kramer Daniel B, Zimetbaum Peter J

机构信息

Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

Medtronic, Inc., Minneapolis, Minnesota.

出版信息

Am J Cardiol. 2015 Jul 1;116(1):85-7. doi: 10.1016/j.amjcard.2015.03.047. Epub 2015 Apr 8.

DOI:10.1016/j.amjcard.2015.03.047
PMID:25933732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4480976/
Abstract

Device longevity in cardiac resynchronization therapy (CRT) is affected by the pacing capture threshold (PCT) and programmed pacing amplitude of the left ventricular (LV) pacing lead. The aims of this study were to evaluate the stability of LV pacing thresholds in a nationwide sample of CRT defibrillator recipients and to determine potential longevity improvements associated with a decrease in the LV safety margin while maintaining effective delivery of CRT. CRT defibrillator patients in the Medtronic CareLink database were eligible for inclusion. LV PCT stability was evaluated using ≥2 measurements over a 14-day period. Separately, a random sample of 7,250 patients with programmed right atrial and right ventricular amplitudes ≤2.5 V, LV thresholds ≤ 2.5 V, and LV pacing ≥90% were evaluated to estimate theoretical battery longevity improvement using LV safety margins of 0.5 and 1.5 V. Threshold stability analysis in 43,256 patients demonstrated LV PCT stability of <0.5 V in 77% of patients and <1 V in 95%. Device longevity analysis showed that the use of a 0.5-V safety margin increased average battery longevity by 0.62 years (95% confidence interval 0.61 to 0.63) compared with a safety margin of 1.5 V. Patients with LV PCTs >1 V had the greatest increases in battery life (mean increase 0.86 years, 95% confidence interval 0.85 to 0.87). In conclusion, nearly all CRT defibrillator patients had LV PCT stability <1.0 V. Decreasing the LV safety margin from 1.5 to 0.5 V provided consistent delivery of CRT for most patients and significantly improved battery longevity.

摘要

心脏再同步治疗(CRT)中设备的使用寿命受左心室(LV)起搏导线的起搏夺获阈值(PCT)和程控起搏幅度影响。本研究旨在评估全国范围内CRT除颤器植入者样本中LV起搏阈值的稳定性,并确定在维持CRT有效输送的同时,与LV安全裕度降低相关的潜在使用寿命改善情况。美敦力CareLink数据库中的CRT除颤器患者符合纳入标准。通过在14天内进行≥2次测量来评估LV PCT稳定性。另外,对7250名程控右心房和右心室幅度≤2.5V、LV阈值≤2.5V且LV起搏≥90%的患者进行随机抽样,以评估使用0.5V和1.5V的LV安全裕度时理论电池使用寿命的改善情况。对43256名患者的阈值稳定性分析表明,77%的患者LV PCT稳定性<0.5V,95%的患者<1V。设备使用寿命分析显示,与1.5V的安全裕度相比,使用0.5V的安全裕度可使平均电池使用寿命延长0.62年(95%置信区间0.61至0.63)。LV PCT>1V的患者电池寿命增加最多(平均增加0.86年,95%置信区间0.85至0.87)。总之,几乎所有CRT除颤器患者的LV PCT稳定性<1.0V。将LV安全裕度从1.5V降至0.5V可为大多数患者持续提供CRT,并显著提高电池使用寿命。